Marc Tessier Lavigne

Title: The Innovations of Marc Tessier Lavigne

Introduction

Marc Tessier Lavigne is a prominent inventor based in San Mateo, CA. He has made significant contributions to the field of neurological research. His work focuses on developing pharmacological agents that can aid in the diagnosis and treatment of neurological diseases.

Latest Patents

Marc Tessier Lavigne holds a patent for "Neurological drug screens." This patent involves compositions for identifying lead compounds that are useful in diagnosing or treating neurological diseases or injuries. The invention includes mixtures comprising an isolated netrin and an isolated natural netrin receptor, such as 'Deleted in Colorectal Carcinoma' (DCC) and neogenin. The general methods described in the patent involve incubating a mixture of an isolated mammalian netrin, an isolated natural mammalian netrin receptor, and a candidate pharmacological agent. The goal is to determine if the presence of the agent modulates the binding of the netrin to the receptor. He has 1 patent to his name.

Career Highlights

Marc Tessier Lavigne is affiliated with the University of California, where he continues to advance research in the field of neuroscience. His work has garnered attention for its potential impact on understanding and treating neurological conditions.

Collaborations

Some of his notable coworkers include David Leonardo and Masayuki Masu. Their collaborative efforts contribute to the innovative research being conducted in the field.

Conclusion

Marc Tessier Lavigne's contributions to neurological research through his patent and collaborations highlight his commitment to advancing medical science. His work has the potential to significantly impact the diagnosis and treatment of neurological diseases.